Hydrogel Delivery of Neural Growth Factors and Stem Cells for the Treatment of Spinal Cord Injuries
Current Research in the Laboratory:
To improve the outcome for children diagnosed with brain tumors, including medulloblastoma, the Cancer Epigenetics Lab, headed by Sigrid A. Langhans, PhD, is taking three complementary approaches to its pediatric cancer research:
- Curcumin Research
- Nanotechnology-based Approaches for Improved Drug Delivery to the Brain
To circumvent the blood-brain barrier, a natural impediment for efficient drug delivery to the brain, researchers at the Cancer Epigenetics lab are developing, in collaboration with the Department of Materials Science and Engineering at the University of Delaware, a nano-hydrogel approach for direct drug delivery to brain tumors. Initial studies confirmed that the hydrogels are suitable drug carriers with a sustained drug release profile. The project was supported by the Center of Biomedical Research Excellence (COBRE) at the University of Delaware.
- Novel Drug Targets
Lunch will be provided.
Host: Ling Cao, MD, PhD
Alfond Room 304